Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00275535 · ClinicalTrials.gov registry record · Phase 4
The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients
A Phase 4 study of Kidney Diseases, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 165
- Enrollment target
- 1
- Study location
NCT00275535: Completed Phase 4 study of Kidney Diseases, sponsored by Mayo Clinic.
NCT00275535 is a Phase 4 study of Kidney Diseases that has completed, run by Mayo Clinic. The registered enrollment target is 165 participants, below the 1,781-participant average among 38 other Kidney Diseases trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00275535, a Phase 4 study of Kidney Diseases, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 165 participants
- Enrollment target
- 1
- Study location
Study Summary
This study was done to find out which treatment, tacrolimus or sirolimus, leads to better long-term kidney function in kidney transplant patients.
Conditions Studied
Interventions
- DRUG Sirolimus
- DRUG Prednisone
- DRUG Tacrolimus
- DRUG Mycophenolate mofetil
- DRUG Anti-thymocyte globulin
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2001-04 |
| Est. Completion | 2008-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00275535
The ClinicalTrials.gov registry entry for NCT00275535 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,781-participant average among 38 other Kidney Diseases trials with a reported enrollment target (91% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Kidney Diseases appearing as the primary indexed condition, and to 5 interventions - of which Sirolimus is the first listed.
NCT00275535 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT00275535 about?
NCT00275535 is a clinical study titled "The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients". This study was done to find out which treatment, tacrolimus or sirolimus, leads to better long-term kidney function in kidney transplant patients.
What is the current status of trial NCT00275535?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 165 participants. The study started on 2001-04. Estimated completion is 2008-12.
What conditions does trial NCT00275535 study?
This clinical trial studies the following conditions: Kidney Diseases.
What interventions are being tested in trial NCT00275535?
The interventions under investigation include: Sirolimus (DRUG), Prednisone (DRUG), Tacrolimus (DRUG), Mycophenolate mofetil (DRUG), Anti-thymocyte globulin (DRUG).
Who is sponsoring clinical trial NCT00275535?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00275535 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease
RECRUITING · NA
-
Rutgers University Study of the Genetics of Kidney Disease
RECRUITING
-
Supporting VETerans With Kidney Disease Through Food As Medicine
RECRUITING · NA
-
Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients
RECRUITING · Phase 3
-
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
RECRUITING · NA
-
Dietary Intervention to Improve Kidney Transplant Outcomes
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.